Stock ASMB ASSEMBLY BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Assembly Biosciences, Inc.

Equities

ASMB

US0453962070

Delayed Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
12.15 USD -8.99% Intraday chart for Assembly Biosciences, Inc. -15.03% +23.46%
Jul. 01 Assembly Biosciences, Inc.(NasdaqGS:ASMB) added to Russell Microcap Growth Index CI
Jul. 01 Assembly Biosciences, Inc.(NasdaqGS:ASMB) added to Russell 3000E Growth Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Assembly Biosciences, Inc.(NasdaqGS:ASMB) added to Russell Microcap Growth Index
CI
Assembly Biosciences, Inc.(NasdaqGS:ASMB) added to Russell 3000E Growth Index
CI
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
AQ
Assembly Biosciences, Inc. Doses First Participant in Phase 1B Clinical Trial Evaluating Next-Generation Capsid
CI
Assembly Biosciences Announces $12.6 Million in Equity Financings
AQ
Assembly Biosciences, Inc. announced that it has received $2.77507 million in funding from Gilead Sciences, Inc.
CI
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
AQ
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
AQ
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor Abi-6250 At the Easl Congress 2024
CI
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
AQ
Assembly Biosciences: Q1 Earnings Snapshot
AQ
Assembly Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
AQ
Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
AQ
Reverse Split: 1 of 12
FA
Assembly Biosciences Announces Effective Date of Reverse Stock Split
GL
Assembly Biosciences Announces Effective Date of Reverse Stock Split
AQ
Assembly Biosciences Insider Bought Shares Worth $511,264, According to a Recent SEC Filing
MT
Assembly Biosciences, Inc. Provides Anticipated Development Milestones for 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASMB Stock
  4. News Assembly Biosciences, Inc.